Evidence map›Paper›PMID 42307983›Full record

ArticleOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2026

Treatment Priorities in Patients With a History of Laryngeal Cancer: A Conjoint Analysis.

Montana K Upton, Sindhura Sridhar, Alexis Miller Dennison, Kavita Prasad, Thomas Issa, Rishi Kondapaneni, Elliot Abemayor, Abie H Mendelsohn, Robert Sinard, Sarah Rohde and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Montana K UptonDepartment of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Sindhura SridharDepartment of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Alexis Miller DennisonDepartment of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kavita PrasadDepartment of Otolaryngology-Head and Neck Surgery at Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Thomas IssaDepartment of Head and Neck Surgery, UCLA, Los Angeles, California, USA.
Rishi KondapaneniDepartment of Otolaryngology-Head and Neck Surgery, University of Missouri, Columbia, Missouri, USA.
Elliot AbemayorDepartment of Head and Neck Surgery, UCLA, Los Angeles, California, USA.
Abie H MendelsohnDepartment of Head and Neck Surgery, UCLA, Los Angeles, California, USA.
Robert SinardDepartment of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Sarah RohdeDepartment of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Patrick TassoneDepartment of Otolaryngology-Head and Neck Surgery, University of Missouri, Columbia, Missouri, USA.
Michael C TopfDepartment of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Funding

Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
Augmented Reality to Guide Head and Neck Cancer SurgeryK08CA293255 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Michael Topf · 2024 to 2026
$645k
NCI NIH HHS 1K08CA293255-0NCI NIH HHS K08 CA293255NCI NIH HHS K12 CA090625
6 · The paper itself

Abstract

objectiveTo investigate patient priorities that may inform the choice of laryngeal cancer treatment. STUDY

designMulti-institutional, survey-based, conjoint analysis study focusing on seven attributes: lifespan, treatment type, cancer cure, self-image, mode of breathing, voicing, and swallowing. Patients with a history of treated laryngeal cancer (>6 months from treatment completion with no evidence of recurrent disease) were recruited.

settingTertiary care medical centers.

methodsConjoint analysis yields utility scores, a quantitative measure of preference for an attribute. Higher utility scores indicate greater preference. Chi-squared, univariate logistic regression, and univariate linear regression analyses were used to evaluate associations between patient demographic and medical features with relative attribute preference.

resultsThis study included 151 patients with previously treated laryngeal cancer. For the cohort, the mean importance scores (±standard deviation) were swallowing 25.7% (±8.4%), lifespan 21.5% (±9.3%), cancer cure 14.0% (±6.4%), mode of breathing 12.8% (±4.8%), voicing 9.2% (±3.5%), treatment type 9.1% (±5.0%), and self-image 7.7% (±4.4%). Patients who required salvage surgery after upfront chemoradiotherapy placed more value on cancer cure compared to the other treatment groups (coefficient 2.76, 95% CI 0.33-5.19).

conclusionIn patients with a history of treated laryngeal cancer, swallowing is the most important treatment priority, followed closely by lifespan. However, patients who underwent salvage surgery placed more value on cancer cure during decision-making. These findings demonstrate that patient treatment preferences are diverse and may change throughout the cancer care journey, with some patients placing a higher value on quality of life than lifespan and cancer cure.

Indexed as

Laryngeal NeoplasmsPatient PreferenceAgedFemaleHumansMaleMiddle AgedSurveys and Questionnairesconjoint analysiscounselinglarynx cancershared decision‐making

Identifiers

PMID42307983
PMCPMC13417992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.